• ACPHS SEMINAR I 2008 SUMMER SCHEDULE   

• ACPHS SEMINAR II 2008 FALL SCHEDULE 

• ACPHS SEMINAR I 2009 SPRING SCHEDULE     

• ACPHS SEMINAR I 2009 SUMMER SCHEDULE        

** Please log on to ACPHS Blackboard to see your schedule for Seminar I & II **

OFFICE LOCATION: AT THE NEW BIOSCIENCE RESEARCH BUILDING – BRB (FORMER PRI)

                            ROOM # 104 A

RESEARCH ARTICLES

1. Villanueva A, Yilmaz MS, Millington WR, Cutrera RA, Stouffer DG, Parsons LH, Cheer JF, Feleder C (2009)  Central Cannabinoid-1 receptor antagonist administration prevents endotoxic hypotension affecting norepinephrine release in the preoptic anterior hypothalamic area. Shock 32(6):614-20

2. Yilmaz MS, Goktalay G , Millington WR, Myer BS, Cutrera RA, Feleder C (2008) Lipopolysaccharide-induced hypotension is mediated by a neural pathway involving the vagus nerve, the nucleus tractus solitarius and alpha-adrenergic receptors in the preoptic anterior hypothalamic area. Neuroimmunology 203:39-49

3. Cansev M, Ilcol YO, Yilmaz MS, Hamurtekin E, Ulus IH (2008) Peripheral administration of CDP-choline, phosphocholine or choline increases plasma glucagon concentrations. Eur J Pharmacol. 589(1-3):315-322

4. Yilmaz MS, Coskun C, Yalcin M, Savci V (2008) CDP-choline prevents cardiac arrhythmias and lethality induced by short-term myocardial ischemia-reperfusion injury in the rat: involvement of central muscarinic cholinergic mechanisms. Naunyn Schmiedeberg’s Arch Pharmacol. 378(3):293-301

5. Yilmaz MS, Coskun C, Suzer O, Yalcin M, Mutlu D, Savci V (2008) Hypotensive effects of intravenously administered uridine and cytidine in conscious rats: the involvement of adenosine receptors. Eur J Pharmacol. 584:125-136

6. Yilmaz MS, Millington WR, Feleder C (2008) The preoptic anterior hypothalamic area mediates initiation of the hypotensive response induced by lipopolysaccharide in male rats. Shock 29:232-237

7. Cansev M, Ilcol YO, Yilmaz MS, Hamurtekin E, Ulus IH (2008) Peripheral administration of CDP-choline, phosphocholine or choline increases plasma adrenaline and noradrenaline concentrations. Autonomic and Autacoid Pharmacology 28:41-58

8. Ilcol YO, Cansev M, Yilmaz MS, Hamurtekin E, Ulus IH (2008) Peripheral administration of CDP-choline and its cholinergic metabolites increases serum insulin: peripheral muscarinic and nicotinic acetylcholine receptors are both involved in its action. Neurosci Lett. 431:71-76

9. Cansev M, Yilmaz MS, Ilcol YO, Hamurtekin E, Ulus IH (2007) Cardiovascular effects of CDP-choline and its metabolites: involvement of peripheral autonomic nervous system. Eur J Pharmacol. 577:129-142

10. Ilcol YO, Cansev M, Yilmaz MS, Hamurtekin E, Ulus IH (2007) Intraperitoneal administration of CDP-choline and its cholinergic and pyrimidinergic metabolites induce hyperglycemia in rats: involvement of the sympathoadrenal system. Arch Physiol Biochem. 113:186-201

11. Yalcin M, Cavun S, Yilmaz MS, Savci V (2006) Activation of the central cholinergic system mediates the reversal of hypotension by centrally administrated U-46619, a thromboxane A2 analog, in hemorrhaged rats. Brain Res. 1118:43-51

12. Yilmaz MS, Yalcin M, Savci V (2006) CDP-choline restores the blood flow of superior mesenteric and renal artery, prolongs the survival time in haemorrhaged anaesthetised rats. Clin Exp Pharmacol Physiol , 33:415-420

13. Yalcin M, Cavun S, Yilmaz MS, Cengiz F, Savci V (2005) The involvement of brain thromboxane A2 in hypo tension induced by haemmorhage in rats. Clin Exp Pharmacol Physiol. 32:960-967

14. Yalcin M, Cavun S, Yilmaz MS, Savci V (2005) The involvement of central cholinergic system in the pressor effect of intracerebroventricularly injected U-46619, a thromboxane A2 analog, in conscious normotensive rats. Naunyn Schmiedeberg’s Arch Pharmacol. 372:31-40

15. Savci V, Goktalay G, Cansev M, Cavun S, Yilmaz MS, Ulus IH (2003) Intravenously injected CDP-choline increases blood pressure and reverses hypotension in haemorrhagic shock: effect is mediated by central cholinergic activation. Eur J Pharmacol. 468:129-139

PRESENTATIONS

- INTERNATIONAL

1. Yilmaz MS, Myer BS, Feleder, Millington WR (2008) Blockade of α-adrenergic receptors in the preoptic area/anterior hypothalamus prevents lipopolysaccharide evoked hypotension. Experimental Biology Meeting 2008, San Diego, CA, U.S.A.

2. Marlow J, Yilmaz MS, Millington WR, Feleder C (2008) A Neural route signals the brain in endotoxic hypotension: Role of the vagus nerve and α-adrenoceptors in the preoptic anterior hypothalamic area. Experimental Biology Meeting 2008, San Diego, CA, U.S.A.

3. Yilmaz MS, Goktalay G, Millington WR, Feleder C (2006) Evidence that the Preoptic Anterior Hypothalamic Area plays a role in lipopolysaccharide induced hypotension. Society for Neuroscience 2006 Congress, Atlanta, GA, U.S.A

4. Feleder C, Yilmaz MS, Goktalay G, Millington WR (2006) Evidence that activation of the vagus nerve initiates the fall in arterial pressure evoked by low, but not high, dose lipoplysacchraride. Society for Neuroscience 2006 Congress, Atlanta, GA, U.S.A

5. Savci V, Yilmaz MS, Yalcin M,  Coskun C (2006) The protective effect of CDP-choline in short term myocardial ischemia-reperfusion injury in rats is mediated by central cholinergic muscarinic activation. Society for Neuroscience 2006 Congress, Atlanta, GA, U.S.A

6. Yilmaz MS, Villanueva A, Millington WR, Cutrera RA, Cheer J, Feleder C (2009) Central Rimonabant Administration Prevents Endotoxic Hypotension by Inhibiting Norepinephrine Release in the Preoptic Anterior Hypothalamic Area. Experimental Biology Meeting 2009, New Orleans, LA, U.S.A.

- NATIONAL

1. Yılmaz MS, Mutlu D, Cansev M, Yalcin M, Savcı V (2005) Cardiovascular effects of intravenously injected uridine and cytidine: The role of adenosine receptors. 18. National Pharmacology Congress, Izmir, Turkey

2. Yilmaz MS, Cansev M, Hamurtekin E, Ulus IH (2004) Effects of CDP-choline and its endogenous metabolites on plasma vasopressin response to graded hemorrhage in rats. 3. National Neuroscience Congress, Denizli, Turkey

3. Hamurtekin E, Cansev M, Yilmaz MS, Ulus IH (2004) Effects of CDP-choline and its endogenous metabolites on plasma catecholamine response to graded hemorrhage in rats. 3. National Neuroscience Congress, Denizli, Turkey

4. Cansev M, Yilmaz MS, Hamurtekin E, Ulus IH (2003) Cardiovascular effects of CDP-choline and its hydrolysis products:Investigating the mechanisms of action. 17. National Pharmacology Congress, Antalya, Turkey

5. Yilmaz MS, Savci V, Ulus IH (2003) Effects of CDP-choline on arteria mesenterica superior and arteria renalis perfusions in haemorrhagic shock. 17. National Pharmacology Congress, Antalya, Turkey

6. Cansev M, Yilmaz MS, Hamurtekin E, Ulus IH (2003). Neuroendocrine effects of CDP-choline and its hydrolysis products: changes in plasma insulin, glucagon and cathecholamine levels. 2. National Neuroscience Congress, Bursa, Turkey

7. Hamurtekin E, Cansev M, Yilmaz MS, Ulus IH (2003). Effects of CDP-choline and its hydrolysis products on serum glucose levels: the role of sympathoadrenal system. 2. National Neuroscience Congress, Bursa, Turkey

8. Yilmaz MS, Hamurtekin E, Cansev M, Ulus IH (2003). Effects of CDP-choline and its hydrolysis products on blood pressure and the role of sympathoadrenal system in the effect. 2. National Neuroscience Congress, Bursa, Turkey

9. Cansev M, Yilmaz MS, Ilcol YO, Ulus IH (2002). Cardiovascular and metabolic-endocrine effects of intraperitoneally injected CDP-choline. 1. National Neuroscience Congress, Eskisehir, Turkey

10. Yilmaz MS, Cansev M, Ilcol YO, Ulus IH (2002). Cardiovascular and metabolic-endocrine effects of intraperitoneally injected choline. 1. National Neuroscience Congress, Eskisehir, Turkey

11. Gurun MS, Genc Z, Koseler A, Yilmaz MS, Ulus IH (2002). The effect of periferic administration of choline on blood glucose and plasma glucagon levels in rats : Description of the mechanisms. 1. National Neuroscience Congress, Eskisehir, Turkey